SCHEMBL6606039

SCHEMBL6606039

Nc1cnn(S)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2155853 0.69
SCHEMBL14829828 0.67
SCHEMBL28208316 0.67
SCHEMBL20445116 0.62
Hydrochloric Acid SCHEMBL31108165 0.44
SCHEMBL12616003 0.44 PI4KA (0.34)
SCHEMBL31490392 0.43
SCHEMBL6278613 0.43
Hydrochloric Acid SCHEMBL15903538 0.41 PTK2 (0.33)
SCHEMBL18623483 0.37 PTK2 (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0877744-B1 SUBSTITUTED AZA- AND DIAZACYCLOHEPTANE AND CYCLOOCTANE COMPOUNDS AND THEIR USE ABBOTT GMBH & CO KG (DE) 2004-08-11 EP disclosed
US-6352981-B1 TREAT DISORDERS WHICH RESPOND TO DOPAMINE D.SUB.3 LIGANDS SUCH AS SCHISTOSOMIASIS, SCHIZOPHRENIA, DEPRESSION, NEUROSES OR PSYCHOSES BASF AKTIENGESELLSCHAFT (DE) 2002-03-05 US disclosed
US-6214822-B1 PSYCHOLOGICAL AND NERVOUS SYSTEM DISORDERS BASF AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
EP-0877744-A1 SUBSTITUTED AZA- AND DIAZACYCLOHEPTANE AND CYCLOOCTANE COMPOUNDS AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1998-11-18 EP disclosed
WO-1997025324-A1 SUBSTITUTED AZA- AND DIAZACYCLOHEPTANE AND CYCLOOCTANE COMPOUNDS AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1997-07-17 WO disclosed